文献速递鼻科

伴鼻息肉的慢性鼻窦炎中黏液与血清生物标志物采样的比较

Comparison of mucus and serum biomarker sampling in chronic rhinosinusitis with nasal polyps.
PubMed 文献 · Int Forum Allergy Rhinol · 2023-11-22

本研究为前瞻性研究,纳入61例伴鼻息肉的慢性鼻窦炎患者,在功能性内镜鼻窦手术后随访24个月、共9个时间点,评估鼻息肉评分并采集黏液和血清检测生物标志物。结果显示所有生物标志物在采样时间点内稳定,血清不可测值比例高于黏液;黏液骨膜蛋白(p<0.001,r=0.89)等组合最能追踪鼻息肉评分变化并预测复发。

要点

  • 血清生物标志物不可测值比例高于黏液生物标志物。
  • 黏液骨膜蛋白(p<0.001,r=0.89)是追踪鼻息肉评分变化的最佳标志物/介质组合。
  • 黏液serpinF2与早期复发负相关并可预测早期复发(p=0.026,R2=0.015)。

核心结论

  • 血清和黏液均可作为「液体活检」的可行介质。
  • 追踪疾病严重程度随时间变化最有前景的生物标志物/介质组合为黏液骨膜蛋白、黏液IgE、血清骨膜蛋白、黏液CST1和血清IgE。
  • 黏液serpinF2是预测早期复发的最佳生物标志物。

研究设计与样本

  • 前瞻性研究,纳入61例伴鼻息肉的慢性鼻窦炎患者。
  • 患者在功能性内镜鼻窦手术后随访24个月,共9个时间点。
  • 每个时间点评估鼻息肉评分(NPS)并采集黏液和血清。
  • 计算均值、标准差和方差、不可测值以及生物标志物与NPS随时间变化及早期复发的相关性,并评估手术对生物标志物的影响。
  • 测量所有生物标志物的昼夜节律以确保采样时间内生物标志物值稳定。

主要发现

  • 所有生物标志物在采样时间点内显示稳定值。
  • 血清生物标志物水平显示不可测值百分比高于黏液生物标志物。
  • 追踪NPS随时间变化和预测复发的最佳标志物/介质组合:黏液骨膜蛋白(p<0.001,r=0.89)、黏液IgE(p<0.001,r=0.51)、血清骨膜蛋白(p<0.001,r=0.53)、黏液CST1(p<0.001,r=0.27)、血清IgE(p<0.01,r=-0.18)。
  • 黏液serpinF2与早期复发负相关并可预测早期复发(p=0.026,R2=0.015)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to analyze advantages and disadvantages of mucus and serum for biomarker analysis. METHODS: This study includes prospective study of 61 CRS with nasal polyps patients who were followed over 24 months and over nine time points after functional endoscopic sinus surgery. At each time points, the nasal polyp score (NPS) was assessed and mucus as well as serum was collected. Selected were measured in mucus and serum. Mean, standard deviation and variance, undetectable values, and the correlation of the biomarkers to the NPS over time and to early recurrences were calculated, and the effect of surgery on the biomarkers was assessed. Additionally, the diurnal rhythm of all biomarkers was measures in order to assure stable biomarker values during sampling times. RESULTS: All biomarkers showed stable values during sampling times. Serum biomarker levels displayed higher percentages of undetectable values compared to mucus biomarkers. Mucus periostin (p < 0.001, r = 0.89), mucus IgE (p < 0.001, r = 0.51), serum periostin (p < 0.001, r = 0.53), mucus CST1 (p < 0.001, r = 0.27), and serum IgE (p < 0.01, r = -0.18) were the best marker and medium combinations to track the NPS over time and to predict recurrences. Mucus serpinF2 was negatively correlated and predicted early recurrences (p = 0.026, R2 = 0.015). CONCLUSIONS: Serum and mucus both represent viable mediums for "liquid biopsies." The most promising biomarker/medium combinations over time to track disease severity were mucus periostin, mucus IgE, serum periostin, mucus CST1, and serum IgE. Mucus serpinF2 was the best biomarker to predict early recurrences.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Mueller SK, Wendler O, Mayr S, et al. Comparison of mucus and serum biomarker sampling in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2023. PMID: 37990964. doi:10.1002/alr.23295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。